Pharmacy Tech Scholar
NOVEMBER 17, 2020
Pharmacy Technician Salary: Expert Insights What do pharmacy technicians make? This is one of the most common questions we are asked by those interested in… The post Pharmacy Technician Salary appeared first on PharmacyTechScholar.com.
pharmaphorum
NOVEMBER 20, 2020
COVID-19 has turned the world on its head and healthcare systems have had to respond rapidly to match the sudden changes created by lockdown. Digital health had already been building a presence before the pandemic, but the tools it offers have been essential to counter the disruption caused by the coronavirus, reports Richard Staines. COVID-19 isn’t going away any time soon but when, and if, this crisis subsides the healthcare systems that are left behind will have changed radically.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
NOVEMBER 19, 2020
The COVID-19 pandemic has undoubtedly accelerated disruption within the digital world. Out of this heavy disruption comes an opportunity for companies to become more innovative-focused and show how quickly they can pivot under pressure. Right now, the pharmaceutical industry is adapting faster than ever before in their marketing strategies due to reduced drug rep access, a (mostly) digital shift, and new and emerging digital and virtual platforms.
Outsourcing Pharma
NOVEMBER 18, 2020
The federal agency has offered updates, advice and action regarding the COVID-19 pandemic, helping life-sciences professionals stay on top of developments.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Druggist
NOVEMBER 17, 2020
Proton pump inhibitors (PPIs) are one of the most commonly prescribed drugs. In fact, when looking at the top 15 most prescribed drugs in the UK , two PPIs made it to the top: omeprazole and lansoprazole. Although not as commonly prescribed as omeprazole, esomeprazole gained its popularity due to wide availability as over the counter medicine. Esomeprazole vs omeprazole is a review of both drugs.
pharmaphorum
NOVEMBER 20, 2020
Doctors in the US are to get another option to treat COVID-19 after the FDA granted an Emergency Use Authorization (EUA) for Eli Lilly’s baricitinib. Baricitinib is the active ingredient in Lilly’s rheumatoid arthritis drug Olumiant and is the latest example of a drug being repurposed to combat COVID-19. Most of the drugs attempt to tackle the inflammation that can cause complications in patients with severe disease.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Outsourcing Pharma
NOVEMBER 18, 2020
A leader from the trial patient services specialist discusses the importance of keeping the participantâs vital role top of mind in research studies.
Druggist
NOVEMBER 19, 2020
Fostair inhaler is a popular combination inhaler used in the management of asthma and COPD. In asthma, Fostair is usually recommended when a condition is not well controlled with the use of inhaled steroid and short-acting beta2-agonist (like Ventolin) or condition is controlled with two separate inhalers (corticosteroid and long-acting beta2-agonists).
pharmaphorum
NOVEMBER 17, 2020
As regional vice president for Northern Europe & Australia, Simon Lem led the digital launch of Vertex Pharma’s novel cystic fibrosis drug Kaftrio. He tells pharmaphorum about embracing digital change and the need for innovative reimbursement solutions. For Vertex, COVID-19 accelerated a digital transformation much needed for the patients they serve.
Pharma Times
NOVEMBER 16, 2020
It is hoped that the move will help to tackle the persistent symptoms – such as fatigue and brain fog – suffered by people who have developed the condition
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Outsourcing Pharma
NOVEMBER 18, 2020
A leader from the CRO discusses how the COVID-19 pandemic has accelerated decentralized adoption, and how such trials lead to benefits for participants.
Mission-Driven Marketing Blog
NOVEMBER 20, 2020
There's been a growing focus on inbound marketing practices as opposed to outbound practices in recent years. Inbound marketing involves promotional channels and tactics that encourage prospective customers to seek out additional information about the business. This is in stark contract to outbound marketing, which centers around promotional tactics to sell a product or service directly to prospective customers.
pharmaphorum
NOVEMBER 17, 2020
Pharmaceutical companies often struggle to actively involve patients in the design phase of clinical trials but doing so can have huge benefits for the sustainability and success of research. It can help address well established issues with studies, such as patient recruitment and retention, as well as reducing the need for additional trial protocol amendments.
Pharma Times
NOVEMBER 17, 2020
MPs launch inquiry with view of securing extra support for sector
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Outsourcing Pharma
NOVEMBER 17, 2020
A leader from the global CRO talks about how use of RWE in clinical trials can benefit research sites and sponsors, and satisfy regulatory requirements.
Pharma Marketing Network
NOVEMBER 20, 2020
This year’s 24 th Annual Healthcare Internet Conference , held on November 16-18, speakers gathered (virtually) to share their thoughts and opinions on how technology is changing the patient and physician relationship, how to grow digital engagement, and how patient experiences are shifting with telemedicine during COVID-19. Here are 3 key sessions from the conference: How Technology is Changing the Patient-Physician Relationship.
pharmaphorum
NOVEMBER 18, 2020
To mark World Antimicrobial Awareness Week NovaBiotics’s Deborah O’Neil tells us why 2021 might be the year anti-infective drugs finally demonstrate their economic value. . COVID-19 has reminded the world how critical infectious disease is, from both a societal and economic standpoint. Cancer is rightly seen as one of the most pressing challenges of our time: but it has not yet caused a multi-trillion hole in the world’s finances.
Pharma Times
NOVEMBER 20, 2020
Service also offers price comparison on generic and branded drugs
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Outsourcing Pharma
NOVEMBER 18, 2020
A leader from the CRO discusses the vital role participants play in a clinical studyâs success, and what it truly means to be patient centric.
Pharma Mirror
NOVEMBER 18, 2020
CPhI & P-MEC China returns as a hybrid event in Shanghai (16-18 December 2020), with a physical exhibition running alongside Virtual Expo Connect (18 November – 18 December 2020)for international audiences unable to attend. The physical exhibition will be held at the SNIEC (Shanghai New International Expo Center), with some 3,000 exhibitors present across three days, alongside exhibitor talks and conferences.
pharmaphorum
NOVEMBER 19, 2020
The FDA has agreed to expedite development of two rare disease drugs from Sanofi. The most significant of the two announcements is the Priority Review for avalglucosidase alfa, a potential new therapy for Pompe disease. The review period will be shortened from the standard ten months to six months or less, and the French pharma said the FDA will make the regulatory decision before May 18th.
Pharma Times
NOVEMBER 17, 2020
Drug combinations tested were found to be well tolerated
Outsourcing Pharma
NOVEMBER 16, 2020
A leader from the clinical research technology firm shares perspective on the benefits Bayesian trial design, an approach dating back to the 1700s.
Druggist
NOVEMBER 17, 2020
Proton pump inhibitors (PPIs) are one of the most commonly prescribed drugs. In fact, when looking at the top 15 most prescribed drugs in the UK , two PPIs made it to the top: omeprazole and lansoprazole. Although not as commonly prescribed as omeprazole, esomeprazole gained its popularity due to wide availability as over the counter medicine. Esomeprazole vs omeprazole is a review of both drugs.
pharmaphorum
NOVEMBER 20, 2020
COVID-19 has left us more reliant on media than ever – both the pharma industry and society as a whole. Havas Lynx Group’s 2020 white paper provides a blueprint for pharma brands to inject meaning into their media. “Meaningful media experiences are made by connecting with the right people, in the contexts they spend their time, with content that drives impact.
Pharma Times
NOVEMBER 18, 2020
Initial purchase includes 225 million doses of mRNA-based vaccine
Outsourcing Pharma
NOVEMBER 19, 2020
The control arm, engineered from historical trial data derived from more than 22,000 previous studies, will be used in a Phase III cancer trial.
Med Ed 101
NOVEMBER 18, 2020
Loop diuretics (podcast episode) are a mainstay of therapy when we need to eliminate fluid from the body. Heart failure and ascites due to cirrhosis are two of the most common fluid overload disease states that these medications will be used for. I wanted to provide some background on loop diuretic conversions as you will […]. The post Loop Diuretic Conversions – Practice Pearls appeared first on Med Ed 101.
pharmaphorum
NOVEMBER 20, 2020
Just over a year after its first phase 3 trial of its Engensis gene therapy for painful diabetic peripheral neuropathy (DPN) bombed, Helixmith has started dosing patients in a new study. The South Korean biotech says the DNA plasmid-based therapy has been administered to a patient at Innovative Research of West Florida. The aim is to enrol 152 DPN patients at 15 clinical sites across the US in the study, called REGAiN-1A.
Pharma Times
NOVEMBER 18, 2020
Designation is based on results from phase IIb/III HPTN 083 trial
Outsourcing Pharma
NOVEMBER 18, 2020
According to one New Yorker, encountering the AI-assisted TrialJectory technology helped cut through the uncertainty to provide information and solutions.
Med Ed 101
NOVEMBER 16, 2020
While pyridoxine (vitamin B6) is a less well-known vitamin compared to cyanocobalamin (vitamin B12), there are some potential consequences from deficiency. I am going to layout pyridoxine clinical pearls including some common medications that may cause deficiency and additional situations where pyridoxine may be used. Isoniazid is an agent used for the treatment of tuberculosis […].
pharmaphorum
NOVEMBER 16, 2020
The antidepressant fluvoxamine merits further investigation as a potential treatment for COVID-19 according to findings of a preliminary trial. Findings of the trial involving 152 outpatients showed fluvoxamine, a selective serotonin reuptake inhibitor and sigma-1 receptor stopped clinical deterioration compared with placebo. All the patients on the US-based trial had confirmed COVID-19 and were randomly assigned to receive either fluvoxamine or placebo, three times daily for 15 days.
Expert insights. Personalized for you.
Let's personalize your content